The reverse engineering of cellular genetic circuits from gene expression data is an important and scientifically challenging problem. When applied to system more complex than a yeast cell, however, most of the approaches for reverse engineering are limited by their reliance on a significant number of ad-hoc perturbation, such as gene knockout. We propose to address these issues and to attempt to reconstruct the genetic circuitry of human B-cells by coupling three distinct components: 1) an information theoretic method for the inference of cellular networks from microarray profile data for a large number of distinct cellular and molecular phenotypes 2) A synthetic network simulation framework for the assessment of the performance of the reverse engineering under a variety of constraints and conditions, such as noise and network complexity. 3) An adaptive learning method that will iteratively apply optimal perturbations to the biological system, which will allow refining the cellular network model over time. Furthermore, we propose to biologically validate this approach by elucidating the cellular networks of human B lymphocytes, from a variety of normal, tumor-derived, and experimentally manipulated B cell phenotypes, which are significant both from an oncological and immunological perspective. This will be accomplished by analyzing an existing set of over 340 high-quality microarray expression profiles. Finally, we will create a software platform to reverse engineer any biological system for which adequate microarray data is available. The platform will also allow to design and perform virtual, in-silico gene perturbation experiments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA109755-02
Application #
7082976
Study Section
Special Emphasis Panel (ZRG1-MABS (01))
Program Officer
Couch, Jennifer A
Project Start
2005-06-21
Project End
2010-04-30
Budget Start
2006-06-01
Budget End
2007-04-30
Support Year
2
Fiscal Year
2006
Total Cost
$373,483
Indirect Cost
Name
Columbia University (N.Y.)
Department
Miscellaneous
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Chiu, Hua-Sheng; Llobet-Navas, David; Yang, Xuerui et al. (2015) Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks. Genome Res 25:257-67
Kushwaha, Ritu; Jagadish, Nirmala; Kustagi, Manjunath et al. (2015) Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency. Stem Cells 33:367-77
Bisikirska, B C; Adam, S J; Alvarez, M J et al. (2013) STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma. Oncogene 32:5283-91
Martinez, Maria Rodriguez; Corradin, Alberto; Klein, Ulf et al. (2012) Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis. Proc Natl Acad Sci U S A 109:2672-7
Sumazin, Pavel; Yang, Xuerui; Chiu, Hua-Sheng et al. (2011) An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147:370-81
Carro, Maria Stella; Lim, Wei Keat; Alvarez, Mariano Javier et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318-25
Lefebvre, Celine; Rajbhandari, Presha; Alvarez, Mariano J et al. (2010) A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol 6:377
Basso, Katia; Saito, Masumichi; Sumazin, Pavel et al. (2010) Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. Blood 115:975-84
Wang, Kai; Saito, Masumichi; Bisikirska, Brygida C et al. (2009) Genome-wide identification of post-translational modulators of transcription factor activity in human B cells. Nat Biotechnol 27:829-39
Zhao, Xudong; D' Arca, Domenico; Lim, Wei Keat et al. (2009) The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev Cell 17:210-21

Showing the most recent 10 out of 18 publications